News for 'laboratories-ltd'

Electoral bonds: Who is lottery king Santiago Martin?

Electoral bonds: Who is lottery king Santiago Martin?

Rediff.com15 Mar 2024

Future Gaming and Hotel Services whose director is the lottery magnate Santiago Martin is the top purchaser of electoral bonds having purchased bonds worth Rs 1,368, according to data uploaded by the Election Commission of India on its website on Thursday.

PM holds meet with teams involved in developing COVID vaccine

PM holds meet with teams involved in developing COVID vaccine

Rediff.com30 Nov 2020

The teams were from Gennova Biopharmaceuticals Ltd Pune, Biological E Ltd Hyderabad and Dr Reddys Laboratories Ltd Hyderabad.

Recent drug recalls worry investors

Recent drug recalls worry investors

Rediff.com19 Mar 2013

Many say trend could lead to concerns on manufacturing quality in Indian facilities.

Pharma firms spend 10% of production cost on tie-ups

Pharma firms spend 10% of production cost on tie-ups

Rediff.com20 Aug 2012

This helps consumers check the authenticity of drugs simply by sending SMSes.

Made in India Sputnik V to be available during Sept-Oct: Dr Reddy's

Made in India Sputnik V to be available during Sept-Oct: Dr Reddy's

Rediff.com27 Jul 2021

Dr Reddy's Laboratories Ltd expects the locally manufactured Russia's COVID-19 vaccine Sputnik V to be available from September-October period, a senior official of the city-based drug maker said.

Matrix Labs eyes Chinese, SA pharma cos

Matrix Labs eyes Chinese, SA pharma cos

Rediff.com27 Dec 2005

Matrix Laboratories Ltd said it has decided to make investments in several pharmaceutical companies in China and in one company in South Africa.

Lupin recalls 9,210 bottles of anti-infective drug from the US

Lupin recalls 9,210 bottles of anti-infective drug from the US

Rediff.com15 Apr 2014

The recent recalls come amid increased FDA scrutiny of medicines produced in India.

Matrix merges 4 firms via swap

Matrix merges 4 firms via swap

Rediff.com30 Mar 2004

Sun Pharma to buy Ranbaxy in $3.2-billion deal

Sun Pharma to buy Ranbaxy in $3.2-billion deal

Rediff.com7 Apr 2014

Sun Pharmaceutical said Ranbaxy shareholders will get 0.8 Sun Pharma shares for each Ranbaxy share.

SC notice to Centre, Ranbaxy on plea for cancelling its licence

SC notice to Centre, Ranbaxy on plea for cancelling its licence

Rediff.com14 Mar 2014

Agreeing to examine the allegations, a bench headed by Chief Justice P Sathasivam, however, refused to pass any interim order for restraining the company from manufacturing drugs.

ASK AJIT: 'Which shares to buy short term and long term?'

ASK AJIT: 'Which shares to buy short term and long term?'

Rediff.com17 Jan 2022

Ajit Mishra, vice president, research, Religare Broking, answers your stockmarket queries.

Substandard drugs: SC's clean chit to Ranbaxy

Substandard drugs: SC's clean chit to Ranbaxy

Rediff.com25 Jun 2013

The petitioner failed to bring in evidence against Ranbaxy, said Supreme Court.

Sun denies insider trading charges in Ranbaxy deal

Sun denies insider trading charges in Ranbaxy deal

Rediff.com9 Apr 2014

Silverstreet Developers LLP, which had no holding in Ranbaxy at the end of September 2013, had bought shares of the Gurgaon-based firm aggregating 1.41 per cent stake by end of December 2013. As on March 31, 2014, its holding stood at 1.64 per cent.

Andhra HC order not to impact merger with Ranbaxy: Sun Pharma

Andhra HC order not to impact merger with Ranbaxy: Sun Pharma

Rediff.com27 May 2014

Last week, the court had vacated the status quo order it had issued earlier on the merger process between Sun Pharma and Ranbaxy.

Court orders temporary halt on Sun Pharma's takeover of Ranbaxy

Court orders temporary halt on Sun Pharma's takeover of Ranbaxy

Rediff.com1 May 2014

Two individuals filed the petition in the high court of Andhra Pradesh

Ranbaxy resumes supply of Atorvastatin tablets in US

Ranbaxy resumes supply of Atorvastatin tablets in US

Rediff.com1 Apr 2013

The company had stopped production of generic version of cholesterol lowering drug Lipitor last year as it investigated the issue of potential glass particles in certain lots of the drug.

BSE imposes margin on two scrips

BSE imposes margin on two scrips

Rediff.com12 Feb 2003

BSE imposed special margin on Cybermate Infoteck Ltd and Vimta Laboratories Ltd.\n\n

Ranbaxy expects guidance on Dewas unit by December

Ranbaxy expects guidance on Dewas unit by December

Rediff.com12 Nov 2012

Work to begin after that on corrective measures to meet US regulator's requirements.

5 stocks that lost money in the recent rally

5 stocks that lost money in the recent rally

Rediff.com22 May 2013

The decline in these was mostly due to company or sector-specific issues, say experts.

Major blow to Ranbaxy's American dream

Major blow to Ranbaxy's American dream

Rediff.com26 Jan 2012

Less than three months after roaring into us market with generic for cholesterol-reducing Lipitor, Dept of Justice files for permanent injunction against Ranbaxy.

Ind-Swift Lab to issue shares

Ind-Swift Lab to issue shares

Rediff.com27 Feb 2003

Ind-Swift Laboratories Ltd okayed preferential issue of 40,00,000 shares.

Ranbaxy to sell Daiichi Sankyo product in Malaysia

Ranbaxy to sell Daiichi Sankyo product in Malaysia

Rediff.com21 Dec 2011

Initially, the domestic firm will market Cravit (levofloxacin) used for treating severe bacterial infections in the Malaysian market from January 1, 2012.

Ranbaxy launches Cefprozil

Ranbaxy launches Cefprozil

Rediff.com11 Feb 2003

Ranbaxy Laboratories Ltd unveiled an advanced Cephalosporin, Cefprozil, under the brand name Refzil O.

A Mylan win in US court could hit Ranbaxy

A Mylan win in US court could hit Ranbaxy

Rediff.com4 Oct 2012

Ranbaxy was scheduled to launch its drug on September 21, the day Diovan's patent expired.

Govt expects speedy launch of single-dose Sputnik Light vaccine

Govt expects speedy launch of single-dose Sputnik Light vaccine

Rediff.com27 May 2021

The government is hopeful of a speedy launch of single-dose COVID-19 vaccine Sputnik Light in India and all stakeholders, including the Russian manufacturer and its Indian partners, have been directed to fast-track the application and regulatory approval procedures for the jab to boost the country's vaccination drive, sources said.

No move yet on chem unit: Ranbaxy

No move yet on chem unit: Ranbaxy

Rediff.com17 Feb 2003

Ranbaxy Laboratories Ltd said it has not taken any decision regarding sale of its chemical unit

Matrix Lab rejects Lundbeck offer

Matrix Lab rejects Lundbeck offer

Rediff.com12 Feb 2003

Matrix Laboratories Ltd said Lundbeck, Denmark, approached the company to stop production of Citalopram. Matrix, however, rejected the offer.

Atorvastatin: Dr Reddy's to contest Pfizer's suit

Atorvastatin: Dr Reddy's to contest Pfizer's suit

Rediff.com5 Jan 2011

On December 27 last year, Pfizer had moved to the US District Court for the District of Delaware against Dr Reddy's Laboratories Ltd and Dr Reddy's Laboratories Inc for infringement of Pfizer's crystalline atorvastatin patent.

Ranbaxy business to be profitable in short term: Sun Pharma

Ranbaxy business to be profitable in short term: Sun Pharma

Rediff.com7 Apr 2014

Sun Pharmaceutical Industries Ltd Chairman Dilip Shanghvi said he expects Ranbaxy Laboratories Ltd to become profitable in the short term.

Ranbaxy denies receiving notice

Ranbaxy denies receiving notice

Rediff.com20 Feb 2003

Ranbaxy Laboratories Ltd said it has not received any notice from National Pharmaceutical Pricing Authority to deposit Rs 15 million as penalty for pricing flaws.

Ind Swift Lab re-issues shares

Ind Swift Lab re-issues shares

Rediff.com18 Feb 2003

Ind Swift Laboratories Ltd re-issued 1,75,900 shares, which were earlier forfeited by the company due to non-payment of allotment/call money.

Dr Reddy's, Leiner Health sign pact

Dr Reddy's, Leiner Health sign pact

Rediff.com24 Feb 2003

Dr Reddy’s Laboratories Ltd and Leiner Health Products signed a 15-year product development and marketing agreement for for Dr Reddys over-the-counter drug products.

Ranbaxy sues US FDA for revoking drug approvals

Ranbaxy sues US FDA for revoking drug approvals

Rediff.com18 Nov 2014

FDA had cancelled Ranbaxy's approvals to launch generic Nexium, Valcyte

Glenmark Pharma to divest stake in arm

Glenmark Pharma to divest stake in arm

Rediff.com8 Feb 2003

Glenmark Pharmaceuticals Ltd plans to divest its subsidiary Glenmark Laboratories Ltd to Mark Saldanha and his associates for Rs 350 million. It also plans to sell its manufacturing plant at Verna, Goa.

Ranbaxy to launch 100 new products this year

Ranbaxy to launch 100 new products this year

Rediff.com28 Apr 2010

Ranbaxy Laboratories Ltd, the country's biggest drug maker by revenues, has announced aggressive growth plans for the domestic market. It has increased its sales teams in specific areas like cardiovascular, diabetics and dermatology and plans to introduce over 100 new products by the year-end.

Ind Swift closes buyback

Ind Swift closes buyback

Rediff.com4 Feb 2003

Ind-Swift Ltd completed buyback of 25,56,600 shares constituting 23.14% stake held by Punjab State Industrial Development Corporation in its sister company Ind-Swift Laboratories Ltd for Rs 82 million.

US patent lawsuit against Dr Reddy's

US patent lawsuit against Dr Reddy's

Rediff.com16 Sep 2009

The patent relates to the manufacturing process for the active ingredient in Sanofi-Aventis' Allegra and Allegra-D drug products. Both Dr Reddys and Sandoz are known to be marketing these products in the US.

Ranbaxy gets FDA nod for hypertension drug

Ranbaxy gets FDA nod for hypertension drug

Rediff.com26 Apr 2004

Ranbaxy Laboratories Ltd has received the US Food and Drug Administration approval to market Fosinopril sodium tablets in the United States.

Glenmark nods sale of subsidiary

Glenmark nods sale of subsidiary

Rediff.com15 Feb 2003

Glenmark Pharmaceuticals Ltd has informed BSE that the Board of Directors of the company at its meeting held on February 14, 2003 has approved divesting its wholly-owned subsidiary Glenmark Laboratories Ltd, including sale of its manufacturing Plant